Exploring the Therapeutic Potential of the DOT1L Inhibitor EPZ004777 Using Bioinformatics and Molecular Docking Approaches in Acute Myeloid Leukemia
Background: Acute myeloid leukemia (AML) is a malignancy characterized by the clonal expansion of hematopoietic stem and progenitor cells, often associated with mutations such as NPM1. DOT1L inhibitors have shown potential as new therapeutic opportunities for NPM1-mutant AML. The aim of this study w...
Saved in:
| Main Authors: | Mehmet Kivrak, Ihsan Nalkiran, Hatice Sevim Nalkiran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/47/3/173 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of MicroRNAs in Chronic Myeloid Leukemia (CML) Treatment, Biomarkers, and Resistance to Tyrosine Kinase Inhibitor: A Bioinformatics-Based Analysis
by: Syarifah Faezah binti Syed Mohamad, et al.
Published: (2024-11-01) -
In Silico Identification of LSD1 Inhibition-Responsive Targets in Small Cell Lung Cancer
by: Ihsan Nalkiran, et al.
Published: (2025-05-01) -
Treatment of acute myeloid leukemia in children
by: A. V. Popa, et al.
Published: (2022-11-01) -
Transcriptomic characterisation of acute myeloid leukemia cell lines bearing the same t(9;11) driver mutation reveals different molecular signatures
by: Elise Georges, et al.
Published: (2025-03-01) -
Corrigendum: Identification of miR-342-5p/MDM4/p53 network in acute myeloid leukemia
by: Sema Misir, et al.
Published: (2025-04-01)